Healthcare - Genomics & Precision Medicine
Companies in gene therapy, genetic testing, and personalized medicine platforms
Gene Therapy & Gene Editing60
RNA Therapeutics10
Genetic Testing & Diagnostics23
Precision Medicine Platforms49
| Ticker | Company | Sub-Theme | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|---|
 AZN | AstraZeneca PLC | Precision Medicine Platforms | $287.9b | $185.08 | +1.8% | 2.3M |
 TMO | Thermo Fisher Scientific, Inc. | Precision Medicine Platforms | $183.0b | $471.55 | -2.2% | 1.7M |
 DHR | Danaher Corporation | Precision Medicine Platforms | $129.3b | $183.90 | -1.5% | 3.3M |
 VRTX | Vertex Pharmaceuticals Inc | Gene Therapy & Gene Editing | $113.6b | $446.93 | +1.2% | 1.5M |
 REGN | Regeneron Pharmaceuticals Inc | Gene Therapy & Gene Editing | $64.5b | $635.40 | +1.1% | 975.8K |
 ALNY | Alnylam Pharmaceuticals, Inc. | RNA Therapeutics | $40.3b | $303.03 | -0.2% | 1.0M |
 WAT | Waters Corp | Precision Medicine Platforms | $37.7b | $364.80 | -3.1% | 676.5K |
 NTRA | Natera, Inc. Common Stock | Genetic Testing & Diagnostics | $32.0b | $215.14 | -3.1% | 849.5K |
 ILMN | Illumina Inc | Genetic Testing & Diagnostics | $24.7b | $162.31 | -3.4% | 2.1M |
 INSM | Insmed, Inc. | Gene Therapy & Gene Editing | $23.2b | $94.15 | -10.3% | 8.0M |
 LH | Labcorp Holdings Inc. | Genetic Testing & Diagnostics | $21.3b | $265.15 | +1.6% | 429.3K |
 GH | Guardant Health, Inc. Common Stock | Precision Medicine Platforms | $17.2b | $125.55 | -5.6% | 3.3M |
 BBIO | BridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $13.0b | $67.61 | +0.4% | 2.6M |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | RNA Therapeutics | $12.6b | $74.49 | -0.9% | 2.0M |
 RVTY | Revvity, Inc. | Precision Medicine Platforms | $11.7b | $98.37 | -3.9% | 868.6K |
 BMRN | BioMarin Pharmaceuticals Inc | Gene Therapy & Gene Editing | $11.1b | $56.76 | +0.5% | 2.2M |
 ARWR | Arrowhead Research Corporation | RNA Therapeutics | $11.0b | $73.09 | -2.8% | 1.2M |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | Precision Medicine Platforms | $9.8b | $253.97 | -4.1% | 617.7K |
 KRYS | Krystal Biotech, Inc. Common Stock | Gene Therapy & Gene Editing | $9.1b | $300.46 | -2.4% | 264.5K |
 TEM | Tempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $9.1b | $46.19 | -11.6% | 8.9M |
 NUVL | Nuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $8.7b | $90.84 | -3.4% | 716.0K |
 TECH | Bio-Techne Corp. | Precision Medicine Platforms | $8.1b | $51.98 | -2.3% | 2.9M |
 QGEN | QIAGEN N.V. | Genetic Testing & Diagnostics | $7.5b | $36.68 | -2.3% | 1.4M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $6.7b | $74.12 | -0.7% | 639.5K |
 LNTH | Lantheus Holdings, Inc | Precision Medicine Platforms | $6.5b | $100.97 | -1.8% | 746.3K |
 CRSP | CRISPR Therapeutics AG | Gene Therapy & Gene Editing | $5.4b | $51.86 | -8.9% | 2.3M |
 CAI | Caris Life Sciences, Inc. Common Stock | Precision Medicine Platforms | $4.7b | $16.51 | -4.5% | 2.7M |
 BLLN | BillionToOne, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $4.6b | $97.15 | -7.1% | 879.5K |
 FOLD | Amicus Therapeutics, Inc | Gene Therapy & Gene Editing | $4.5b | $14.49 | +0.0% | 3.5M |
 TWST | Twist Bioscience Corporation Common Stock | Precision Medicine Platforms | $4.2b | $69.19 | -6.4% | 2.5M |
 VCYT | Veracyte, Inc. | Genetic Testing & Diagnostics | $3.7b | $48.74 | -2.4% | 1.2M |
 TXG | 10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $3.6b | $31.05 | -7.3% | 3.8M |
 BEAM | Beam Therapeutics Inc. Common Stock | Gene Therapy & Gene Editing | $3.4b | $29.34 | -10.7% | 2.4M |
 DYN | Dyne Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $3.2b | $17.05 | -7.4% | 1.9M |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | Precision Medicine Platforms | $2.6b | $28.30 | -3.2% | 710.9K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | Precision Medicine Platforms | $2.4b | $16.89 | -6.6% | 2.2M |
 NTLA | Intellia Therapeutics, Inc | Gene Therapy & Gene Editing | $2.0b | $13.30 | -9.8% | 7.5M |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | Gene Therapy & Gene Editing | $1.9b | $15.75 | -5.5% | 2.7M |
 QURE | uniQure N.V. | Gene Therapy & Gene Editing | $1.8b | $26.54 | -5.2% | 1.5M |
 VCEL | Vericel Corporation | Gene Therapy & Gene Editing | $1.7b | $36.30 | +1.7% | 558.3K |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | Gene Therapy & Gene Editing | $1.7b | $5.50 | -6.6% | 1.4M |
 PGEN | Precigen, Inc. Common Stock | Gene Therapy & Gene Editing | $1.5b | $3.56 | -7.8% | 5.3M |
 WGS | GeneDx Holdings Corp. Class A Common Stock | Precision Medicine PlatformsGenetic Testing & Diagnostics | $1.5b | $52.28 | -7.1% | 1.2M |
 MAZE | Maze Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $1.5b | $24.25 | -4.5% | 445.6K |
 NEO | NeoGenomics, Inc. | Genetic Testing & Diagnostics | $1.4b | $10.90 | -3.6% | 1.0M |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | RNA Therapeutics | $1.3b | $5.74 | -5.8% | 4.0M |
 BLFS | BioLife Solutions Inc. | Gene Therapy & Gene Editing | $1.2b | $26.65 | -1.6% | 701.9K |
 PSNL | Personalis, Inc. Common Stock | Genetic Testing & Diagnostics | $1.2b | $10.73 | -11.3% | 4.1M |
 CDNA | CareDx, Inc. | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $1.2b | $22.27 | -3.7% | 548.4K |
 OPK | Opko Health Inc. | Genetic Testing & Diagnostics | $1.1b | $1.43 | -2.0% | 3.9M |